Women's Health

For more than a decade, the Feminist Majority Foundation has been encouraging and advocating for clinical trials using mifepristone, anti-progesterone compound medication formerly known as RU 486 (the abortion pill), for progesterone-receptor positive cancers primarily affecting women. Now, the Feminist Majority Foundation has put together a team of prestigious clinical researchers, attorneys, and FDA specialists, and is moving ahead with Phase II clinical trials for women with progesterone-dependent uterine and ovarian cancers. This type of cancer accounts for 60 percent of breast cancers, 85 percent of uterine cancers and 40 percent of ovarian cancers. Your help is crucial in moving the ground-breaking research forward. We need you to make as large a contribution as you possibly can afford. We want you to participate. When all else fails, feminists will and can make women's health research move forward. Move Women's Cancer Research Forward FMF's Mifepristone Compassionate Use Program Breast Cancer Resources Reproductive Rights Women's Health News 12/11/2008 Abortion Opponents Lobby to Remove Planned Parenthood Funding GO>> 12/1/2008 Today is 20th Anniversary of World AIDS Day GO>> 11/17/2008 The Dangerous Masquerade of “Crisis Pregnancy Centers” GO>> 10/28/2008 Egypt Finally Convicts a Sexual Harasser GO>> 10/14/2008 Medicaid to Cover Genetic Tests for Breast and Ovarian Cancers in Illinois GO>>       October is Breast Cancer Awareness Month Learn more at the Breast Cancer Information Center, and look for articles in the Fall 2005 issue of Ms. Magazine.